Fluciclovine-PET Uptake in Microcystic Meningioma Mimicking High-grade Glioma: A Case Report
A 69-year-old asymptomatic woman underwent magnetic resonance imaging (MRI), revealing a left parietal lobe tumor suspected to be a high-grade glioma (HGG). [ 18 F]Fluciclovine-positron emission tomography (PET), which reflects amino acid metabolism, showed moderate uptake [SUVmax 1.4, tumor-to-normal ratio (TNR) 1.9], consistent with HGG, whereas [ 18 F]fluorodeoxyglucose-PET findings demonstrated low uptake (SUVmax 2.5, TNR 0.22), which is atypical for HGG. Surgical and pathologic investigations confirmed the diagnosis of microcystic meningioma, a rare subtype classified as grade 1. Microcystic meningiomas mimic HGG on magnetic resonance imaging and [ 18 F]fluciclovine-PET due to l -amino acid transporter expression, complicating diagnosis.
Authors
- Kohsuke Kudo (ORCID: https://orcid.org/0000-0001-5351-9242)
- Yukitomo Ishi (ORCID: https://orcid.org/0000-0003-4834-2619)
- Kenji Hirata (ORCID: https://orcid.org/0000-0003-0036-8975)
- Shiro Watanabe
- Junki Takenaka (ORCID: https://orcid.org/0000-0002-6049-4474)
Institutions
- Hokkaido University (JP)
- Hokkaido University Hospital (JP)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1097/rlu.0000000000005924
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00